Parexel International (ma) Corporation
Location
Massachusetts
Founded
1983-02-28
Website
Risk Signals
455 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Parexel International (ma) Corporation
Live alerts from global media, monitored by Business Radar
2017-05-10 (endpts.com)
As M&A buzz heats up, Parexel plans 1,200 layoffs; Grünenthal is hiring for its new Boston/Cambridge center
→ As rumors of a potential buyout spread following a move to cut projected revenue, the big CRO Parexel is laying the groundwork for a major cut in staff. In a filing with the SEC on May 4, the Waltham, MA-based company outlined plans to slash up to 1,200 jobs at
Read more
(pe-insights.com)
Private equity majors circle $9bn-valued Parexel as Pamplona Capital mulls exit options | Private Equity Insights
Contract research firm Parexel is said to garner takeover interest from Private equity giant EQT and a consortium of three other buyout majors.
Read more
(biospace.com)
Global Clinical Research Firm Parexel to Be Acquired for $8.5 Billion
Upon completion of the merger, Parexel will be owned by EQT IX Fund and the private equity business within Goldman Sachs Asset Management.
Read more